Price Alert

F-star Therapeutics Inc. (FSTX)

NASDAQ: FSTX · Real-Time Price · USD

7.12

0.00 (0.00%)

At close: Mar 08, 2023, 10:00 PM

F-star Therapeutics Statistics

Share Statistics

F-star Therapeutics has 21.98M shares outstanding. The number of shares has increased by 0% in one year.

Shares Outstanding	21.98M
Shares Change (YoY)	0%
Shares Change (QoQ)	0%
Owned by Institutions (%)	n/a
Shares Floating	21.58M
Failed to Deliver (FTD) Shares	131,574
FTD / Avg. Volume	17.61%

Short Selling Information

The latest short interest is 1.23M, so 0% of the outstanding shares have been sold short.

Short Interest	1.23M
Short % of Shares Out	n/a
Short % of Float	6.36%
Short Ratio (days to cover)	3.46

Valuation Ratios

The PE ratio is -2.67 and the forward PE ratio is null. F-star Therapeutics's PEG ratio is 0.08.

PE Ratio	-2.67
Forward PE	n/a
PS Ratio	3.95
Forward PS	n/a
PB Ratio	0.86
P/FCF Ratio	-2.99
PEG Ratio	0.08

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for F-star Therapeutics.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.98, with a Debt / Equity ratio of 0.14.

Current Ratio	6.98
Quick Ratio	7.17
Debt / Equity	0.14
Debt / EBITDA	-0.45
Debt / FCF	-0.47
Interest Coverage	-36.39

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$251.99K
Profits Per Employee	$-372.42K
Employee Count	84
Asset Turnover	0.17
Inventory Turnover	n/a

Taxes

Income Tax	-372K
Effective Tax Rate	1.18%

Stock Price Statistics

The stock price has increased by 0% in the last 52 weeks. The beta is -0.35, so F-star Therapeutics's price volatility has been lower than the market average.

Beta	-0.35
52-Week Price Change	n/a
50-Day Moving Average	5.48
200-Day Moving Average	5.52
Relative Strength Index (RSI)	70.9
Average Volume (20 Days)	747,281

Income Statement

In the last 12 months, F-star Therapeutics had revenue of 21.17M and earned -31.28M in profits. Earnings per share was -1.88.

Revenue	21.17M
Gross Profit	21.17M
Operating Income	-30.71M
Net Income	-31.28M
EBITDA	-29.42M
EBIT	-30.81M
Earnings Per Share (EPS)	-1.88

Full Income Statement

Balance Sheet

The company has 78.55M in cash and 13.23M in debt, giving a net cash position of 65.31M.

Cash & Cash Equivalents	78.55M
Total Debt	13.23M
Net Cash	65.31M
Retained Earnings	-78.45M
Total Assets	83.72M
Working Capital	34.93M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -27.27M and capital expenditures -658K, giving a free cash flow of -27.93M.

Operating Cash Flow	-27.27M
Capital Expenditures	-658K
Free Cash Flow	-27.93M
FCF Per Share	-1.68

Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of -145.1% and -147.79%.

Gross Margin	100%
Operating Margin	-145.1%
Pretax Margin	-149.55%
Profit Margin	-147.79%
EBITDA Margin	-138.99%
EBIT Margin	-145.1%
FCF Margin	-131.93%

Dividends & Yields

FSTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

Currently there are no analyst rating for FSTX.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	0.67
Piotroski F-Score	3